ECG Belt vs. Echocardiographic Optimization of CRT
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 110 |
| Updated: | 8/4/2018 |
| Start Date: | October 31, 2017 |
| End Date: | September 2019 |
| Contact: | Chris Brown |
| Email: | Christopher.Brown2@allina.com |
| Phone: | 651-241-2806 |
Optimization of New CRT Recipients: Subjects Randomized to ECG Belt or Echocardiographic Optimization
Cardiac resynchronization therapy (CRT) has been a valuable intervention for patients with
systolic heart failure for over 15 years. Despite years of research, there is a still a
25-40% non-responder rate depending on the outcomes measured. CRT optimization is a term used
to describe the act of individualizing the therapy (CRT programming) for an individual
patient. This is not often performed, but when it is, echocardiography is utilized. Recent
work of body surface mapping using a novel system called the ECG Belt has shown a
relationship between measures of electrical dyssynchrony and acute and chronic heart pumping
function. This study will compare outcomes of patients randomized to either echocardiographic
or ECG Belt optimization of CRT devices.
systolic heart failure for over 15 years. Despite years of research, there is a still a
25-40% non-responder rate depending on the outcomes measured. CRT optimization is a term used
to describe the act of individualizing the therapy (CRT programming) for an individual
patient. This is not often performed, but when it is, echocardiography is utilized. Recent
work of body surface mapping using a novel system called the ECG Belt has shown a
relationship between measures of electrical dyssynchrony and acute and chronic heart pumping
function. This study will compare outcomes of patients randomized to either echocardiographic
or ECG Belt optimization of CRT devices.
This is a prospective randomized study designed to determine whether cardiac
resynchronization therapy (CRT) device programming guided by the ECG Belt (Medtronic, PLC)
improves echocardiographic and functional outcomes in heart failure (HF) patients. The
population will include patients treated with CRT for standard indications (not implanted for
the sole purposes of this study). The study will focus enrollment on patients who do not have
baseline characteristics predicting the best CRT response. Therefore the study will not
enroll patients having non-ischemic HF etiology, left bundle branch (LBBB) morphology, and
QRSd > 150 ms or those previously RV paced.
resynchronization therapy (CRT) device programming guided by the ECG Belt (Medtronic, PLC)
improves echocardiographic and functional outcomes in heart failure (HF) patients. The
population will include patients treated with CRT for standard indications (not implanted for
the sole purposes of this study). The study will focus enrollment on patients who do not have
baseline characteristics predicting the best CRT response. Therefore the study will not
enroll patients having non-ischemic HF etiology, left bundle branch (LBBB) morphology, and
QRSd > 150 ms or those previously RV paced.
Inclusion Criteria:
- Willing and able to provide informed consent for participation in the study
- Age ≥18 years
- Received a first-time CRT device for standard clinical indication (can be upgraded
from non-CRT pacemaker or defibrillator if ventricular pacing < 10%)
- Adequate echocardiographic images for EF & LVESV determination
Exclusion Criteria:
- Unhealed open wounds on the torso and/or a history of documented severe allergic
reactions from ECG electrode gel
- Enrollment in a concurrent study that could confound the results of this study
- Pregnant or could become pregnant within the 6 month follow-up period
- Non-ischemic cardiomyopathy, LBBB morphology, and QRSd > 150 ms
- Dysrhythmia (AF or PVCs) that will likely result in aggregate ventricular pacing < 90%
over the 6 month follow-up period
We found this trial at
1
site
Click here to add this to my saved trials
